iBio, Inc.
Cash Flow Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-16.1M | $-14.5M | $-9.8M | $-6.6M | $-3.7M | $-6.2M | $-5.7M | $-12.1M |
| Depreciation & Amortization | — | — | — | — | — | — | $329.7K | $376.8K |
| Depreciation | $1.4M | $1.3M | $577.0K | $5.0K | $3.0K | $2.0K | $7.0K | — |
| Amortization | $341.0K | $350.0K | $363.0K | $358.0K | $358.0K | $336.0K | $323.0K | $373.0K |
| Stock-Based Compensation | $770.0K | $1.0M | $1.2M | $914.0K | $1.1M | $1.3M | $2.7M | $3.9M |
| Net Cash from Operating Activities | $-13.5M | $-13.2M | $-8.1M | $-4.7M | $-4.1M | $-4.8M | $-6.0M | $-5.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $934.0K | $1.3M | $68.0K | $13.0K | $4.0K | $7.0K | $1.0K | $1.2K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-1.1M | $-1.6M | — | — | — | $-195.0K | $-245.0K | $-94.1K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $22.4M | $-170.0K | — | — | — | $3.8M | $9.0M | $7.4M |
| Net Change in Cash | $7.8M | $-14.9M | $13.5M | $5.9M | $-824.0K | $-1.2M | $2.8M | $1.9M |
| Free Cash Flow | $-14.4M | $-14.5M | $-8.1M | $-4.7M | $-4.1M | $-4.9M | $-6.0M | $-5.3M |